Search
for
Sort by
Research 181–210 of 1000+
- Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis
- Baricitinib for the Treatment of Alopecia Areata
- Renal tubular dysfunction presenting as recurrent hypokalemic periodic quadriparesis in systemic lupus erythematosus
- Friend or foe: A systematic review of dupilumab and alopecia areata
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Industry updates in advanced therapy medicinal products and regenerative medicine – March 2026
- Exploring novel management options for alopecia areata
- Combination Therapy for Extensive Tumoral Calcinosis in Juvenile Dermatomyositis
- Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- From the Cochrane Library: Interventions for Nail Psoriasis
- Hair
- Refractory Myasthenia Gravis and Concurrent Alopecia Areata Postthymectomy With Improvements After Cortisone Taper: A Case Report
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- Assessment of Multidimensional Health Care Parameters Among Adults in Japan for Developing a Virtual Human Generative Model: Protocol for a Cross-sectional Study